The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of ARQ 761, a β-lapachone analog that promotes NQO1-mediated programmed cancer cell necrosis.
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Samsung Bioepis
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - ArQule (Inst); BerGenBio (Inst); ImClone Systems (Inst); Immunogen (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
Travel, Accommodations, Expenses - ArQule; Bristol-Myers Squibb; Lilly; Lilly
 
Ajit Kumar Bisen
No Relationships to Disclose
 
Muhammad Shaalan Beg
No Relationships to Disclose
 
Arthur E. Frankel
No Relationships to Disclose
 
Oluwatomilade Fatunde
No Relationships to Disclose
 
Farjana Fattah
No Relationships to Disclose
 
Yull Edwin Arriaga
No Relationships to Disclose
 
Jonathan Dowell
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Genentech
Research Funding - Astex Pharmaceuticals; MedImmune; Taiho Pharmaceutical; Verastem
 
Claudia Meek
No Relationships to Disclose
 
Joyce D. Bolluyt
No Relationships to Disclose
 
Venetia Sarode
No Relationships to Disclose
 
Xin Luo
No Relationships to Disclose
 
Yang Xie
No Relationships to Disclose
 
Brian E. Schwartz
No Relationships to Disclose
 
David A. Boothman
No Relationships to Disclose
 
Richard Leff
No Relationships to Disclose